Rosenthal, P., Schwarz, K. B., Gonzalez‐Peralta, R. P., Lin, C., Kelly, D. A., Nightingale, S., . . . Wirth, S. (2019). Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection. Hepatology.
Chicago ZitierstilRosenthal, Philip, et al. "Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection." Hepatology 2019.
MLA ZitierstilRosenthal, Philip, et al. "Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection." Hepatology 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.